Ethyl 4-(4-fluorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 90%, 1g

2-(Pyridin-2-yl)benzo[d]oxazole, 97.0%, 5g

2,5-Difluoromandelic acid, 97.0%, 5g

MeO-2PACz>98.0%(T)500mg

N,N,2-Trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 10g

4-fluoro-N-(pyridin-2-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg

METHYL 5-(4-CYANOPHENYL)ISOXAZOLE-3-CARBOXYLATE, 95.0%, 10g

N-cyclopentyl-3-nitro-2-pyridinamine, 95.0%, 1g

(E)-4-Oxo-4-phenylbut-2-enoic acid, 95.0%, 25g

4,6-Dichloro-5-nitropyrimidine, 97.0%, 1g

Pair of HWF 20x/10mm eyepieces

((Z)-2-((3S,4S,5S)-3,5-Bis((tert-butyldimethylsilyl)oxy)-4-(3-((tert-butyldimethylsilyl)oxy)propoxy)-2-methylenecyclohexylidene)ethyl)diphenylphosphine oxide, 97%, 100mg

(2S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxopentanoic acid, 97%, 50mg